Trump Administration Cuts Threaten Pittsburgh Alzheimer's Study
Quick Brief
The Trump administration has canceled a federal research grant for an Alzheimer's disease study focusing on low-income, majority Black neighborhoods in Pittsburgh. Researchers now face a 90-day shutdown order that leaves them without the time or funds to return cognitive test results to the 600 participating aging adults.
What Happened?
In August, the Trump administration canceled a federal research grant examining Alzheimer's disease risk in two low-income, majority Black neighborhoods in Pittsburgh, Pennsylvania. Investigators were given a 90-day window to shut down the project, cutting the timeline short by more than five months and leaving them unable to assess and share collected data with trial participants.
Why It Matters
The sudden termination of the grant disrupts critical health research on Alzheimer's disease in vulnerable populations. Furthermore, the abrupt closure prevents 600 aging adults from receiving the results of their cognitive tests, depriving them of important personal health data.
Key Facts
- The Trump administration canceled a federal research grant studying Alzheimer's disease risk in Pittsburgh in August.
- The study focused on two low-income, majority Black neighborhoods.
- Researchers were given a 90-day window to shut down the project, more than five months ahead of schedule.
- The cancellation affects 600 aging adults participating in the trial.
- Investigators lack the necessary time and funding to assess and share cognitive test data with participants.
Compiled from 1 outlet
Related Stories
Chronic Shortage of Health Play Staff in English Hospitals Exposes Children to Avoidable Trauma
New analysis reveals a severe shortage of health play professionals in English hospitals, with only 955 workers supporting millions of child admissions. These professionals use games, toys, and activities to help young patients cope with the anxiety of medical treatments. Without adequate support, experts warn that children are suffering from lasting trauma during their hospital stays.
Life-Extending Breast Cancer Drug Secured for NHS Patients in England
Following a successful pricing agreement between government ministers and the manufacturer, the life-extending medication Enhertu will be provided on the NHS in England. An initial decision regarding the treatment had previously been rejected, but the new accord reverses that stance. Approximately 1,000 women annually with a specific advanced form of the disease are expected to benefit.
Measles Outbreak in Bangladesh Claims Lives of Over 1,000 Children
A severe measles outbreak in Bangladesh has resulted in the deaths of over 1,000 children. This tragic toll reverses the substantial progress the country had made toward eliminating the disease as of March this year.
Fiji Declares National HIV Emergency Amid Rising Infections and Methamphetamine Use
Fiji has officially declared a national HIV emergency following a significant increase in infections linked to rising methamphetamine use. Health authorities report that standard outbreak responses are no longer adequate for the escalating epidemic.